東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Antiarrhythmic drugs

Martínez-Rubio, Antoni.

Linked to FindBook

Google Book

Amazon

博客來

Antiarrhythmic drugs

Record Type:	Electronic resources : Monograph/item
Title/Author:	Antiarrhythmic drugs/ edited by Antoni Martínez-Rubio, Juan Tamargo, G.-Andrei Dan.
other author:	Martínez-Rubio, Antoni.
Published:	Cham :Springer Nature Switzerland : : 2024.,
Description:	xv, 521 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction: Cardiac arrhythmias a clinical problem -- Electrophysiological basis of the arrhythmias -- Class I antiarrhythmic drugs (Na+ channel blockers) -- Potassium-channel blockers -- Betablockers -- Modulation of calcium handling/Calcium-channel modulators -- Other antiarrhythmic drugs: Novel targets for AADs -- Non-antiarrhythmic drugs with antiarrhythmic effects -- Clinical management of the arrhythmias.
Contained By:	Springer Nature eBook
Subject:	Myocardial depressants. -
Online resource:	https://doi.org/10.1007/978-3-031-74046-6
ISBN:	9783031740466

Antiarrhythmic drugs
Antiarrhythmic drugs[electronic resource] /edited by Antoni Martínez-Rubio, Juan Tamargo, G.-Andrei Dan. - Second edition. - Cham :Springer Nature Switzerland :2024. - xv, 521 p. :ill., digital ;24 cm.

Introduction: Cardiac arrhythmias a clinical problem -- Electrophysiological basis of the arrhythmias -- Class I antiarrhythmic drugs (Na+ channel blockers) -- Potassium-channel blockers -- Betablockers -- Modulation of calcium handling/Calcium-channel modulators -- Other antiarrhythmic drugs: Novel targets for AADs -- Non-antiarrhythmic drugs with antiarrhythmic effects -- Clinical management of the arrhythmias.

This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment. Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.

ISBN: 9783031740466

Standard No.: 10.1007/978-3-031-74046-6doiSubjects--Topical Terms:

1966173
Myocardial depressants.

LC Class. No.: RM347

Dewey Class. No.: 615.716

Antiarrhythmic drugs
LDR:02040nmm a2200337 a 4500 001 2389573
003 DE-He213
005 20250217115404.0
006 m d
007 cr nn 008maaau
008 250916s2024 sz s 0 eng d
020 $a 9783031740466 $q (electronic bk.)
020 $a 9783031740459 $q (paper)
024 7 $a 10.1007/978-3-031-74046-6 $2 doi
035 $a 978-3-031-74046-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RM347
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 615.716 $2 23
090 $a RM347 $b .A629 2024
245 0 0 $a Antiarrhythmic drugs $h [electronic resource] / $c edited by Antoni Martínez-Rubio, Juan Tamargo, G.-Andrei Dan.
250 $a Second edition.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xv, 521 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction: Cardiac arrhythmias a clinical problem -- Electrophysiological basis of the arrhythmias -- Class I antiarrhythmic drugs (Na+ channel blockers) -- Potassium-channel blockers -- Betablockers -- Modulation of calcium handling/Calcium-channel modulators -- Other antiarrhythmic drugs: Novel targets for AADs -- Non-antiarrhythmic drugs with antiarrhythmic effects -- Clinical management of the arrhythmias.
520 $a This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment. Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
650 0 $a Myocardial depressants. $3 1966173
650 0 $a Atrial fibrillation $x Chemotherapy. $3 2016712
650 0 $a Ventricular tachycardia. $3 3755323
650 1 4 $a Cardiology. $3 861477
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Therapeutics. $3 680391
700 1 $a Martínez-Rubio, Antoni. $3 3755321
700 1 $a Tamargo, Juan. $3 3448881
700 1 $a Dan, G.-Andrei. $3 3755322
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-74046-6
950 $a Medicine (SpringerNature-11650)